+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Scoliosis Drug"

From
From
Idiopathic Scoliosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Idiopathic Scoliosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Idiopathic Scoliosis - Pipeline Insight, 2024 - Product Thumbnail Image

Idiopathic Scoliosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Scoliosis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat scoliosis, a condition in which the spine curves abnormally. These drugs are used to reduce pain, improve mobility, and slow the progression of the condition. Common treatments include physical therapy, bracing, and surgery. In some cases, drugs may be prescribed to reduce inflammation and pain. The Scoliosis Drug market is highly competitive, with a range of products available from both generic and branded manufacturers. Companies in the market include Pfizer, Merck, Novartis, and Sanofi. Other players include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more